These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25844260)

  • 21. Antimicrobial activity of the imipenem/rifampicin combination against clinical isolates of Acinetobacter baumannii grown in planktonic and biofilm cultures.
    Wang Y; Bao W; Guo N; Chen H; Cheng W; Jin K; Shen F; Xu J; Zhang Q; Wang C; An Y; Zhang K; Wang F; Yu L
    World J Microbiol Biotechnol; 2014 Dec; 30(12):3015-25. PubMed ID: 25298216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.
    Saballs M; Pujol M; Tubau F; Peña C; Montero A; Domínguez MA; Gudiol F; Ariza J
    J Antimicrob Chemother; 2006 Sep; 58(3):697-700. PubMed ID: 16895941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of Colistin-Ampicillin/Sulbactam Combination Efficacy in Imipenem-Resistant Acinetobacter baumannii Strains].
    Cıkman A; Ceylan MR; Parlak M; Karahocagil MK; Berktaş M
    Mikrobiyol Bul; 2013 Jan; 47(1):147-51. PubMed ID: 23390912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro effectiveness of colistin, tigecycline and levofloxacin alone and combined with clarithromycin and/or heparin as lock solutions against embedded Acinetobacter baumannii strains.
    Ozbek B; Mataraci E
    J Antimicrob Chemother; 2013 Apr; 68(4):827-30. PubMed ID: 23203948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonal spread of multidrug-resistant Acinetobacter baumannii in eastern Taiwan.
    Chang KC; Lin MF; Lin NT; Wu WJ; Kuo HY; Lin TY; Yang TL; Chen YC; Liou ML
    J Microbiol Immunol Infect; 2012 Feb; 45(1):37-42. PubMed ID: 22154678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models.
    Parra Millán R; Jiménez Mejías ME; Sánchez Encinales V; Ayerbe Algaba R; Gutiérrez Valencia A; Pachón Ibáñez ME; Díaz C; Pérez Del Palacio J; López Cortés LF; Pachón J; Smani Y
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4464-70. PubMed ID: 27161639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis.
    Dinc G; Demiraslan H; Elmali F; Ahmed SS; Metan G; Alp E; Doganay M
    Chemotherapy; 2013; 59(5):325-9. PubMed ID: 24525528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features.
    Boral B; Unaldi Ö; Ergin A; Durmaz R; Eser ÖK;
    Ann Clin Microbiol Antimicrob; 2019 Jul; 18(1):19. PubMed ID: 31266519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Detection of Class-D OXA Carbapenemase Genes in Biofilm and Non-Biofilm Forming Clinical Isolates of Acinetobacter baumannii.
    Azizi O; Shakibaie MR; Modarresi F; Shahcheraghi F
    Jundishapur J Microbiol; 2015 Jan; 8(1):e21042. PubMed ID: 25789134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro evaluation of antimicrobial combinations against imipenem-resistant Acinetobacter baumannii of different MICs.
    Zhu W; Wang Y; Cao W; Cao S; Zhang J
    J Infect Public Health; 2018; 11(6):856-860. PubMed ID: 30057349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore.
    Lim TP; Tan TY; Lee W; Sasikala S; Tan TT; Hsu LY; Kwa AL
    J Antibiot (Tokyo); 2009 Dec; 62(12):675-9. PubMed ID: 19876075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. OXA-type Carbapenemases and Susceptibility of Colistin and Tigecycline Among Carbapenem-Resistant Acinetobacter Baumannii Isolates from Patients with Bacteremia in Turkey.
    Cakirlar FK; Ciftci IH; Gonullu N
    Clin Lab; 2015; 61(7):741-7. PubMed ID: 26299073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination Treatment with Intravenous Tigecycline and Intraventricular and Intravenous Colistin in Postoperative Ventriculitis Caused by Multidrug-resistant Acinetobacter baumannii.
    Mizrahi CJ; Benenson S; Moscovici S; Candanedo C; Benifla M; Spektor S
    Cureus; 2019 Jan; 11(1):e3888. PubMed ID: 30911445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.
    Sheng WH; Wang JT; Li SY; Lin YC; Cheng A; Chen YC; Chang SC
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):380-6. PubMed ID: 21558048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of genetic diversity, biofilm formation, and detection of Carbapenemase, MBL, ESBL, and tetracycline resistance genes in multidrug-resistant
    Ranjbar R; Farahani A
    Antimicrob Resist Infect Control; 2019; 8():172. PubMed ID: 31719975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
    Hu YF; Liu CP; Wang NY; Shih SC
    BMC Infect Dis; 2016 Aug; 16(1):444. PubMed ID: 27553962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of colistin or sulbactam in combination with fosfomycin or imipenem against clinical isolates of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemases.
    Santimaleeworagun W; Wongpoowarak P; Chayakul P; Pattharachayakul S; Tansakul P; Garey KW
    Southeast Asian J Trop Med Public Health; 2011 Jul; 42(4):890-900. PubMed ID: 22299471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic analysis of in vivo acquired resistance to colistin and rifampicin in Acinetobacter baumannii.
    Jaidane N; Naas T; Mansour W; Radhia BB; Jerbi S; Boujaafar N; Bouallegue O; Bonnin RA
    Int J Antimicrob Agents; 2018 Feb; 51(2):266-269. PubMed ID: 29127051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro antimicrobials activity against endemic Acinetobacter baumannii multiresistant clones.
    Rodriguez CH; De Ambrosio A; Bajuk M; Spinozzi M; Nastro M; Bombicino K; Radice M; Gutkind G; Vay C; Famiglietti A
    J Infect Dev Ctries; 2010 Mar; 4(3):164-7. PubMed ID: 20351457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.